The Society for Immunotherapy of Cancer (SITC) hosted Session 106d during the 38th Annual Meeting & Pre-Conference Programs on Friday, November 3, 2023. Available here are the presentation slides and video from “Session 106d: Transforming Therapies with Project Optimus: A conversation with the FDA around how to apply and integrate project Optimus into novel clinical trials” as permitted by presenters.
Mirat Shah, MD – FDA
Cecilia Yeung, MD – Fred Hutchinson Cancer Center
To view the entire program schedule (including presenter permission to post) please click here.
SITC 2023 Annual Meeting: Friday, November 301:36:53